The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci195228 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Michael J Martens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics and. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Machine Learning, Prediction Algorithms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
BACKGROUND Chronic graft-versus-host disease (cGVHD) is a major contributor to nonrelapse mortality (NRM) following hematopoietic cell transplantation (HCT). Whether machine-learning (ML) models with biomarkers improve the accuracy for predicting future cGVHD/NRM is not established. METHODS We developed BIOPREVENT (BIOmarkers PREVENTion), a ML algorithm using data from 1,310 HCT recipients, incorporating 7 plasma proteins measured at Day 90/100 post-HCT and 9 clinical variables. Patients were divided into training and validation datasets. ML models — including CoxXGBoost, Group SCAD, Adaptive Group Lasso, Random Survival Forests, and Bayesian Additive Regression Trees (BART) — were used to estimate time-varying Area Under the ROC Curve (AUCt) at Days 180, 270, 360, and 540. Deep learning models were also evaluated. RESULTS ML models with biomarkers outperformed clinical-only models for predicting cGVHD, with BART and CoxXGBoost achieving AUCt greater than 0.65 at 1 year. For NRM, models with biomarkers achieved AUCt ranging from 0.75–0.91. Deep learning did not outperform other ML approaches. BART consistently demonstrated high predictive accuracy and was selected for the final BIOPREVENT model. Calibration curves aligned with observed values. Variable importance analysis identified MMP3 and CXCL9 as key for cGVHD prediction and IL1RL1 and sCD163 for NRM. Cumulative incidences of cGVHD and NRM differed significantly based on BIOPREVENT-defined cutpoints. CONCLUSION BIOPREVENT accurately predicts individual risk of future cGVHD and NRM using biomarkers at 3 months post-HCT. A publicly available R Shiny web application supports its clinical use. Further studies are needed to explore its role in guiding preemptive therapy. TRIAL REGISTRATION BMTCTN 0201, BMTCTN 1202, and NCT02194439. FUNDING R01CA264921, U10HL069294, U24HL138660, R01HD074587, and P01HL158505.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biostatistics and.
- Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Hollings Cancer Center and.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Martens, M. J., Dutta, D., Yu, Y., Rein, L. E., Ritz, J., Logan, B. R., & Paczesny, S. (2026). The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers. Journal of Clinical Investigation. https://doi.org/10.1172/jci195228
Vancouver
Martens MJ, Dutta D, Yu Y, Rein LE, Ritz J, Logan BR, et al. The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers. Journal of Clinical Investigation. 2026. doi:10.1172/jci195228
BibTeX
@article{Martens2026,
author = {Martens, Michael J and Dutta, Debjani and Yu, Yongzi and Rein, Lisa E and Ritz, Jerome and Logan, Brent R and Paczesny, Sophie},
title = {The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci195228}
}
EUVIMED